HoldsUp

Mark Hyman, MD · 2025-05-28 · Mark Hyman (host), Jeff Bland

Longevity Doctor: I’m 79 With the Health of a 40 Year Old, Here’s How I Did It!

33 research-tied claims examined: 4 contradicted 5 overstated 3 context 16 supported 5 unverified

5

Overstated

0:02:12Jeff Blandoverstatedlow

When a person is ill and their immune system is activated, approximately 50% of their metabolic energy is consumed by the immune system.

"Do you realize that when you are ill and your immune system is activated that 50% of your metabolic energy is being consumed by your immune system?" (said at 0:02:12)

While activation of the immune system requires significant energetic resources and redirects nutrient allocation (such as glucose) away from other tissues during infection, the assertion that the immune system consumes approximately 50% of total metabolic energy during general illness is an overstatement. In theoretical bioenergetic frameworks of severe systemic inflammation (such as severe sepsis or major polytrauma), total resting energy expenditure can increase by 20% to 50% (partly driven by fever, increased cardiorespiratory work, hepatic acute-phase protein synthesis, and immunocyte metabolism), and the activated immune system becomes a major consumer of energy. However, for typical illness and immune activation, the direct metabolic consumption of the immune system does not reach 50% of total whole-body metabolic energy expenditure.

0:20:15Jeff Blandoverstatedmoderate

Mitochondria make up 70% of the volume of cardiac cells.

"Gee, what cells are high in mitochondria? Oh, the cardiac cells, 70% of volume is mitochondria; the neurons in the brain." (said at 0:20:15)

While cardiac myocytes have one of the highest mitochondrial densities of any cell type, mitochondria do not comprise 70% of their cellular volume. Established morphometric data and physiological literature indicate that mitochondria occupy approximately 30% to 40% of adult cardiomyocyte volume, with myofibrils (the contractile apparatus) occupying the majority of the remaining cellular space (roughly 50% to 60%).

0:21:04Mark Hyman (host)overstatedlow

Pediatric neurologist Suzanne Goh used MRI technology to identify mitochondrial energy deficits in the brains of children with autism and found clinical improvement when treating them with mitochondrial support nutrient cofactors.

"Suzanne Goh from Harvard and Oxford, incredible pediatric neurologist who's been on the podcast, did a lot of work looking at autism and the brains of autistic kids using very sophisticated MRI technology, looking at mitochondrial energy function in the brain and seeing these kids all had energy deficits, and then used mitochondrial support nutrients, basically cofactors that help with the pathways of producing energy, to help treat these kids with autism and actually found improvement in these kids with autism." (said at 0:21:04)

Suzanne Goh co-authored a landmark 2014 magnetic resonance spectroscopic imaging (MRSI) study demonstrating in vivo markers of brain mitochondrial dysfunction (elevated brain lactate) in individuals with autism spectrum disorder (ASD). However, the claim overstates both the prevalence and the published therapeutic findings. The study identified brain lactate elevations in only 13% of individuals with ASD (and only 6% of children with ASD), characterizing mitochondrial dysfunction as a distinct neurobiological subtype rather than a universal finding ('these kids all had energy deficits'). Furthermore, while mitochondrial support cofactors (such as carnitine, CoQ10, or B vitamins) are used clinically for this subgroup, Goh's published academic research did not report clinical trial outcomes evaluating improvement from mitochondrial nutrient cocktails.

0:55:54Jeff Blandoverstatedlow

Clinical studies show that dietary elimination protocols and specific flavonoids regulate B cells and regulatory T cells (Tregs).

"Those clinical studies have been done and published showing exactly what you said, that it has an effect on B cells and has effect on Tregs, the thymus-dependent regulatory cells. And we now know the genes that actually are regulated by specific flavonoids that ultimately affect the personality of those immune cells that then speak to your B cells to change your antibodies." (said at 0:55:54)

The speaker claims that published clinical studies demonstrate that dietary elimination protocols and specific flavonoids regulate B cells and regulatory T cells (Tregs) to alter antibody production. While mechanistic in vitro and animal models show that certain dietary flavonoids can modulate intracellular signaling in B cells and T-cell subsets (including Tregs), evidence in human clinical trials remains preliminary, mixed, and far less definitive than claimed. Systemic reviews of human clinical trials note that the immunomodulatory effects of flavonoids in humans are controversial and inconclusive due to compound diversity, bioavailability, and variable dosing, rather than well-established clinical proof.

1:05:04Mark Hyman (host)overstatedmoderate

It often takes up to 30 years for scientific research findings to be translated into clinical medical practice.

"people don't want to wait around for 30 years till science gets turned into medical practice, which is often what it takes." (said at 1:05:04)

While scientific literature in implementation science confirms a substantial time lag between research discovery and widespread clinical adoption, the widely cited benchmark across health services research is an average of approximately 17 years, not 30 years. Studies evaluating the translational pipeline from basic science or early clinical trials to routine practice report average translation times ranging from roughly 11 to 17 years.

Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.